Literature DB >> 31300246

Do Astrocytes Play a Role in Intellectual Disabilities?

Noémie Cresto1, Laure-Elise Pillet2, Pierre Billuart3, Nathalie Rouach4.   

Abstract

Neurodevelopmental disorders, including those involving intellectual disability, are characterized by abnormalities in formation and functions of synaptic circuits. Traditionally, research on synaptogenesis and synaptic transmission in health and disease focused on neurons, however, a growing number of studies have highlighted the role of astrocytes in this context. Tight structural and functional interactions of astrocytes and synapses indeed play important roles in brain functions, and the repertoire of astroglial regulations of synaptic circuits is large and complex. Recently, genetic studies of intellectual disabilities have underscored potential contributions of astrocytes in the pathophysiology of these disorders. Here we review how alterations of astrocyte functions in disease may interfere with neuronal excitability and the balance of excitatory and inhibitory transmission during development, and contribute to intellectual disabilities.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Down syndrome; Rett syndrome; astrocytes; fragile X syndrome; intellectual disability; tripartite synapse

Year:  2019        PMID: 31300246     DOI: 10.1016/j.tins.2019.05.011

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  10 in total

Review 1.  Astrocyte: A Foe or a Friend in Intellectual Disability-Related Diseases.

Authors:  Busong Wang; Lu Zou; Min Li; Liang Zhou
Journal:  Front Synaptic Neurosci       Date:  2022-06-23

2.  Astrocytes modulate extracellular neurotransmitter levels and excitatory neurotransmission in dorsolateral striatum via dopamine D2 receptor signaling.

Authors:  Louise Adermark; Oona Lagström; Anna Loftén; Valentina Licheri; Amy Havenäng; Eleonora Anna Loi; Rosita Stomberg; Bo Söderpalm; Ana Domi; Mia Ericson
Journal:  Neuropsychopharmacology       Date:  2021-11-22       Impact factor: 8.294

3.  Metabolic reprogramming in astrocytes results in neuronal dysfunction in intellectual disability.

Authors:  Haibin Zhang; Qiuyang Zheng; Tiantian Guo; Shijun Zhang; Shuang Zheng; Ruimin Wang; Qingfang Deng; Guowei Yang; Shuo Zhang; Linxin Tang; Qiuping Qi; Lin Zhu; Xiu-Fang Zhang; Hong Luo; Xian Zhang; Hao Sun; Yue Gao; Hongfeng Zhang; Ying Zhou; Aidong Han; Chen-Song Zhang; Huaxi Xu; Xin Wang
Journal:  Mol Psychiatry       Date:  2022-03-25       Impact factor: 13.437

Review 4.  Balancing serendipity and reproducibility: Pluripotent stem cells as experimental systems for intellectual and developmental disorders.

Authors:  Nickesha C Anderson; Pin-Fang Chen; Kesavan Meganathan; Wardiya Afshar Saber; Andrew J Petersen; Anita Bhattacharyya; Kristen L Kroll; Mustafa Sahin
Journal:  Stem Cell Reports       Date:  2021-04-15       Impact factor: 7.765

5.  Alterations in Excitatory and Inhibitory Synaptic Development Within the Mesolimbic Dopamine Pathway in a Mouse Model of Prenatal Drug Exposure.

Authors:  Taylor Boggess; James C Williamson; Ethan B Niebergall; Hannah Sexton; Anna Mazur; Richard D Egleton; Lawrence M Grover; W Christopher Risher
Journal:  Front Pediatr       Date:  2021-12-13       Impact factor: 3.418

6.  Identification of Region-Specific Cytoskeletal and Molecular Alterations in Astrocytes of Mecp2 Deficient Animals.

Authors:  Elena Albizzati; Elena Florio; Federica Miramondi; Irene Sormonta; Nicoletta Landsberger; Angelisa Frasca
Journal:  Front Neurosci       Date:  2022-02-15       Impact factor: 4.677

Review 7.  Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease.

Authors:  Octavio García; Lisi Flores-Aguilar
Journal:  Front Cell Neurosci       Date:  2022-09-20       Impact factor: 6.147

Review 8.  Emerging evidence for astrocyte dysfunction in schizophrenia.

Authors:  Eva Cristina de Oliveira Figueiredo; Corrado Calì; Francesco Petrelli; Paola Bezzi
Journal:  Glia       Date:  2022-05-30       Impact factor: 8.073

9.  A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome.

Authors:  Keiji Kawatani; Toshihiko Nambara; Nobutoshi Nawa; Hidetaka Yoshimatsu; Haruna Kusakabe; Katsuya Hirata; Akira Tanave; Kenta Sumiyama; Kimihiko Banno; Hidetoshi Taniguchi; Hitomi Arahori; Keiichi Ozono; Yasuji Kitabatake
Journal:  Commun Biol       Date:  2021-06-14

10.  Evidence of Energy Metabolism Alterations in Cultured Neonatal Astrocytes Derived from the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Bruna L Zampieri; Alberto C S Costa
Journal:  Brain Sci       Date:  2022-01-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.